2 results
Approved WMOCompleted
The objective of this project is to assess the applicability of [18F]PK209 for in vivo imaging of the NMDA receptor.
Approved WMOPending
Main Objective:To demonstrate the superiority of galcanezumab versus placebo in the prevention of migraine in (at least) 1 of the following populations with migraine: the overall pediatric population (6 to 17 year-olds) or the adolescent population…